Merck : MRK

All Merck Articles

1088 Articles

Jon C. Ogg | Apr 14, 2015 at 12:15 PM EDT

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

The 30-year Treasury Bond yields only about 2.5% and, amazingly, more than half of the 30 Dow Jones Industrial Average…

Lee Jackson | Apr 7, 2015 at 10:30 AM EDT

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

SunTrust Robinson Humphrey analysts expect the pharmaceutical industry to outperform in 2015, driven in part by a solid new product…

Paul Ausick | Mar 18, 2015 at 4:01 PM EDT

The 4 Stocks That Boosted the DJIA on Wednesday

thinkstockMarch 18, 2015: Markets opened lower on Wednesday and bided its time below the break-even line until just after 2…

Lee Jackson | Mar 11, 2015 at 9:40 AM EDT

4 Top Pharmaceutical Stocks to Buy for Market Safety

A new research report from SunTrust Robinson Humphrey is very positive on pharmaceuticals, and the analysts expect the sector to…

Jon C. Ogg | Mar 6, 2015 at 12:20 PM EST

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

With AT&T dropped from the Dow in favor of Apple, investors may be wondering which Dow stocks could get booted…

Paul Ausick | Feb 9, 2015 at 4:01 PM EST

The 4 Stocks That Weighed Down The DJIA on Monday

thinkstock February 9, 2015: Markets opened lower on Monday following remarks by Greece’s new president that rattled traders. There was…

Lee Jackson | Feb 5, 2015 at 10:00 AM EST

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

If there is one thing that the pharmaceutical industry tries to shy away from it is the controversy over the…

Chris Lange | Feb 4, 2015 at 9:40 AM EST

Loss of Hep C Drug Status Weighs on Merck Earnings

Merck reported largely in-line fourth-quarter financial results Wednesday before the U.S. markets opened.

Chris Lange | Feb 1, 2015 at 8:56 AM EST

The Top 10 Corporate Earnings for the Week Ahead

24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming…

Paul Ausick | Jan 18, 2015 at 8:20 AM EST

Merck Is Top DJIA Stock in 2015

Merck shares posted a new 52-week high last Tuesday and closed Friday less than a buck from that high. Year…

Jon C. Ogg | Jan 9, 2015 at 11:25 AM EST

The Bullish and Bearish Case for Pfizer in 2015

One key consideration for the year ahead is that the Pfizer of 2016 or 2017 is likely to be night…

Paul Ausick | Jan 8, 2015 at 11:35 AM EST

The Bullish and Bearish Case for Merck in 2015

One key consideration for the year ahead is Merck's acquisitions of Idenix and Cubist Pharmaceuticals to expand its product offerings

Jon C. Ogg | Jan 8, 2015 at 8:15 AM EST

The Bullish and Bearish Case for Johnson & Johnson in 2015

One key consideration for the year ahead is that Johnson & Johnson raised its dividends again and managed to have…

Paul Ausick | Jan 7, 2015 at 4:01 PM EST

The 4 Stocks That Lifted the DJIA on Wednesday

thinkstockJanuary 7, 2015: Markets opened higher on Wednesday after ADP and TrimTab reports on unemployment came in a shade above…

Lee Jackson | Jan 6, 2015 at 8:45 AM EST

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

A new resort from UBS highlights the firm's first Equity Focus list for 2015. Here are five of the highest…

1 … 44 45 46 47 48 … 73

Merck : MRK

All Merck Articles

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

The 4 Stocks That Boosted the DJIA on Wednesday

4 Top Pharmaceutical Stocks to Buy for Market Safety

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

The 4 Stocks That Weighed Down The DJIA on Monday

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Loss of Hep C Drug Status Weighs on Merck Earnings

The Top 10 Corporate Earnings for the Week Ahead

Merck Is Top DJIA Stock in 2015

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Merck in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

The 4 Stocks That Lifted the DJIA on Wednesday

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

Merck : MRK

All Merck Articles

Over Half of DJIA Stocks Outyield 30-Year Treasury Bond

4 Big Pharmaceutical Stocks to Buy for the Rest of 2015

The 4 Stocks That Boosted the DJIA on Wednesday

4 Top Pharmaceutical Stocks to Buy for Market Safety

After Apple Added to DJIA, at Least 3 More Dow Stocks Could Get Booted

The 4 Stocks That Weighed Down The DJIA on Monday

Large Cap Pharmaceutical Stocks to Buy Despite Negative Pricing Headlines

Loss of Hep C Drug Status Weighs on Merck Earnings

The Top 10 Corporate Earnings for the Week Ahead

Merck Is Top DJIA Stock in 2015

The Bullish and Bearish Case for Pfizer in 2015

The Bullish and Bearish Case for Merck in 2015

The Bullish and Bearish Case for Johnson & Johnson in 2015

The 4 Stocks That Lifted the DJIA on Wednesday

5 Top Dividend Yielding Stocks on UBS’s First 2015 Equity Focus List

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60

A Caller’s Dad Turned $22,000 Into $1 Million on a Single Stock. Now the Family Faces a $150,000 Tax Decision

Featured Reads

This 15-Minute Task Is All You Need to Know What Social Security Benefit to Expect

The 401(k) Vesting Cliff That Cost One Worker $74,000 Before Age 60